MedicaidCoverageHigh impact
Silver State Scripts Board Made Changes to the Preferred Drug List Effective May 1, 2026
Nevada Medicaid·NV · Neurology, Cardiology, Pulmonology +4 more·Pharmacy
Effective date
May 1, 2026
We identified it
Jun 21, 2026
Summary
Nevada Medicaid made extensive changes to their Preferred Drug List effective May 1, 2026, affecting multiple drug classes including ADHD medications, cardiovascular agents, inhaled corticosteroids, and adding new categories for Parkinson's and hereditary angioedema treatments. Many drugs were removed due to discontinuation, moved between preferred/non-preferred status, or had prior authorization requirements added.
Action Required
Immediately: Update prior authorization processes for affected Nevada Medicaid patients. Review patient medication lists for drugs removed from PDL (Daytrana patches, Flovent, Pulmicort Flexhaler, Frova, Treximet) and coordinate with providers for alternative therapies. Update billing system to reflect new prior authorization requirements for preferred drugs in HAE classes and other modified medications. Train staff on new drug classifications to prevent claim denials.